BR9914018A - Derivado de cianofenila - Google Patents

Derivado de cianofenila

Info

Publication number
BR9914018A
BR9914018A BR9914018-7A BR9914018A BR9914018A BR 9914018 A BR9914018 A BR 9914018A BR 9914018 A BR9914018 A BR 9914018A BR 9914018 A BR9914018 A BR 9914018A
Authority
BR
Brazil
Prior art keywords
substituted
group
cyanophenyl derivative
application
derivative
Prior art date
Application number
BR9914018-7A
Other languages
English (en)
Inventor
Nobuaki Taniguchi
Isao Kinoyama
Takashi Kamikubo
Akira Toyoshima
Kiyouhiro Samizu
Eiji Ka Waminani
Masakazu Imamura
Hiroyuki Moritomo
Akira Matsuhisa
Masaaki Hirano
Yoji Miyazaki
Eisuke Nozawa
Minoru Okada
Hiroshi Koutoku
Mitsuaki Ohta
Original Assignee
Yamanouchi Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceuticals Co filed Critical Yamanouchi Pharmaceuticals Co
Publication of BR9914018A publication Critical patent/BR9914018A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms

Abstract

"DERIVADO DE CIANOFENILA" Novos derivados de cianofenila substituídos por piperazino, nos quais um grupo carbamoíla ou sulfamoíla substituído, contendo um grupo arila ou heterocíclico opcionalmente substituído ou similar, está ligado ao átomo de nitrogênio que constitui o anel de piperazina. Estes derivados exibem atividades antiandrogênio e são, portanto, úteis na prevenção ou no tratamento de câncer prostático, hipertrofia prostática e assim por diante.
BR9914018-7A 1998-09-22 1999-09-21 Derivado de cianofenila BR9914018A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26750898 1998-09-22
JP15539899 1999-06-02
PCT/JP1999/005149 WO2000017163A1 (fr) 1998-09-22 1999-09-21 Derives de cyanophenyle

Publications (1)

Publication Number Publication Date
BR9914018A true BR9914018A (pt) 2001-07-03

Family

ID=26483414

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914018-7A BR9914018A (pt) 1998-09-22 1999-09-21 Derivado de cianofenila

Country Status (13)

Country Link
US (2) US6673799B1 (pt)
EP (1) EP1122242B1 (pt)
JP (1) JP3390744B2 (pt)
KR (1) KR100660309B1 (pt)
CN (1) CN1129581C (pt)
AT (1) ATE384048T1 (pt)
AU (1) AU754529B2 (pt)
BR (1) BR9914018A (pt)
CA (1) CA2345146C (pt)
DE (1) DE69938005T2 (pt)
ES (1) ES2300151T3 (pt)
PL (1) PL346795A1 (pt)
WO (1) WO2000017163A1 (pt)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517884B2 (en) * 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
AU2001264376A1 (en) * 2000-06-15 2001-12-24 Chaconne Nsi Co., Ltd. Urea derivative useful as an anti-cancer agent and process for preparing same
WO2002008221A2 (en) * 2000-07-20 2002-01-31 Neurogen Corporation Capsaicin receptor ligands
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
EP1335907B1 (en) * 2000-11-20 2010-06-09 Biovitrum AB (publ) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
GB0105895D0 (en) * 2001-03-09 2001-04-25 Smithkline Beecham Plc Novel compounds
MXPA03010612A (es) 2001-05-22 2004-04-02 Neurogen Corp Ligandos receptores de la hormona concentradora de melanina: analogos de 1-bencil-4-aril piperazina substiruidos.
DE60217363T2 (de) 2001-09-06 2007-10-11 Schering Corp. 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen-abhängigen erkrankungen
JPWO2003029199A1 (ja) * 2001-09-28 2005-01-13 武田薬品工業株式会社 ベンゼン誘導体、その製造法および用途
AU2002360932A1 (en) * 2001-11-23 2003-06-10 Schering Aktiengesellschaft Piperazine derivatives destabilising androgen receptors
US6861432B2 (en) 2001-11-23 2005-03-01 Schering Aktiengesellschaft Piperazine derivatives that destabilize androgen receptors
AU2003212882A1 (en) 2002-02-01 2003-09-02 Euro-Celtique S.A. 2 - piperazine - pyridines useful for treating pain
AR039156A1 (es) 2002-03-28 2005-02-09 Novartis Ag Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide
ATE384698T1 (de) 2002-06-28 2008-02-15 Euro Celtique Sa Therapeutische piperazin-derivate für die behandlung von schmerzen
WO2004007471A1 (ja) 2002-07-12 2004-01-22 Yamanouchi Pharmaceutical Co., Ltd. Ｎ−フェニル−（２ｒ，５ｓ）ジメチルピペラジン誘導体
US7262194B2 (en) 2002-07-26 2007-08-28 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7157462B2 (en) 2002-09-24 2007-01-02 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7132539B2 (en) 2002-10-23 2006-11-07 The Procter & Gamble Company Melanocortin receptor ligands
ATE409065T1 (de) 2002-12-17 2008-10-15 Schering Corp Inhibitoren der 17 beta- hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
EP1654221A2 (en) * 2003-06-10 2006-05-10 Smithkline Beecham Corporation Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
CN1856484B (zh) 2003-07-24 2010-09-22 欧洲凯尔蒂克公司 用于治疗或预防疼痛的杂芳基-四氢吡啶基化合物
CA2536349A1 (en) 2003-08-22 2005-03-03 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
US20050124625A1 (en) * 2003-10-21 2005-06-09 Salvati Mark E. Piperazine derivatives and their use as modulators of nuclear hormone receptor function
BRPI0416208A (pt) * 2003-11-20 2006-12-26 Warner Lambert Co moduladores de receptores de androgênio
NZ548209A (en) 2003-12-19 2009-07-31 Univ California Methods and materials for assessing prostate cancer thearapies
WO2005099693A2 (en) 2004-02-24 2005-10-27 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US8519158B2 (en) 2004-03-12 2013-08-27 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
EP1734963A4 (en) 2004-04-02 2008-06-18 Merck & Co Inc METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
DE102004022897A1 (de) * 2004-05-10 2005-12-08 Bayer Cropscience Ag Azinyl-imidazoazine
US20080045504A1 (en) * 2004-05-11 2008-02-21 Pfizer Products Inc. Benzonitrile Derivatives to Treat Musculoskeletal Frailty
US20070004679A1 (en) * 2004-05-17 2007-01-04 Nathalie Schlienger Androgen receptor modulators and methods of treating disease using the same
MXPA06013329A (es) * 2004-05-17 2007-02-22 Acadia Pharm Inc Moduladores del receptor androgeno, y metodo para tratar enfermedades en el que se utilizan los mismos.
US20070190079A1 (en) * 2004-10-29 2007-08-16 Kalypsys, Inc. Methods for the selective modulation of ppar
DK1805158T3 (en) * 2004-10-29 2018-08-06 Kalypsys Inc SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR
NZ555974A (en) * 2005-01-10 2010-11-26 Acadia Pharm Inc Aminophenyl derivatives as selective androgen receptor modulators
US20060173037A1 (en) * 2005-01-10 2006-08-03 Nathalie Schlienger Aminophenyl derivatives as selective androgen receptor modulators
KR20230003445A (ko) 2005-05-13 2023-01-05 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴히단토인 화합물
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
US8193357B2 (en) * 2005-06-17 2012-06-05 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds
CA2624383C (en) * 2005-10-25 2014-03-11 Kalypsys, Inc. Salts of modulators of ppar and methods of treating metabolic disorders
US7825122B2 (en) 2005-12-14 2010-11-02 Amgen Inc. Diaza heterocyclic sulfonamide derivatives and their uses
BRPI0707537A2 (pt) 2006-02-07 2011-05-03 Wyeth Corp inibidores de 11-beta hsd1
EP2368550B1 (en) 2006-03-27 2013-09-04 The Regents of the University of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
SG170809A1 (en) 2006-03-29 2011-05-30 Univ California Diarylthiohydantoin compounds
US20070249519A1 (en) * 2006-04-20 2007-10-25 Kalypsys, Inc. Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease
AR060937A1 (es) * 2006-05-16 2008-07-23 Kalypsys Inc Compuestos biciclicos sustituidos con sulfonilo como moduladores de ppar
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
PE20130325A1 (es) 2007-04-27 2013-03-18 Purdue Pharma Lp Derivados de piperidina, piperazina o tetrahidropiridilo como antagonistas de trpv1
JP5292390B2 (ja) * 2007-08-07 2013-09-18 武田薬品工業株式会社 アンドロゲン受容体調節剤としてのピロリジン−２−オン誘導体
TW201716385A (zh) 2007-10-26 2017-05-16 加州大學董事會 二芳基乙內醯脲類化合物
KR20100099742A (ko) 2007-12-21 2010-09-13 아스트라제네카 아베 안드로겐 수용체 관련 병태의 치료에서 사용하기 위한 이환식 유도체
DE102008041214A1 (de) 2008-08-13 2010-02-18 Bayer Cropscience Ag N-substituierte Azinylakyl-azincarboxamide und deren Analoge
TW201111378A (en) 2009-09-11 2011-04-01 Bayer Schering Pharma Ag Substituted (heteroarylmethyl) thiohydantoins
AR078793A1 (es) 2009-10-27 2011-12-07 Orion Corp Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
EP2536708A4 (en) 2010-02-16 2013-05-29 Aragon Pharmaceuticals Inc ANDROGEN RECEPTOR MODULATORS AND USES THEREOF
ES2533990T3 (es) * 2010-02-24 2015-04-16 Research Triangle Institute Antagonistas de receptores opioides de arilpiperazina
BR112013009274A2 (pt) * 2010-10-22 2018-05-02 Astellas Pharma Inc. antagonista para receptor de andrógeno mutante
ES2541295T3 (es) 2011-04-21 2015-07-17 Orion Corporation Carboxamidas que modulan el receptor de andrógenos
EP3173411B1 (en) 2011-06-22 2018-05-09 Purdue Pharma L.P. Trpv1 antagonists including dihydroxy substituent and uses thereof
US20140275105A1 (en) * 2011-10-21 2014-09-18 Astellas Pharma Inc. Crystal of androgen receptor antagonistic compound
CN104661658A (zh) 2012-09-26 2015-05-27 阿拉贡药品公司 用于治疗非转移性去势抵抗性前列腺癌的抗雄激素
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
JP2016516005A (ja) 2013-02-25 2016-06-02 ノバルティス アーゲー 新規のアンドロゲンレセプター変異
CN103965159B (zh) * 2014-05-17 2017-04-12 广州医科大学 醚类芳基哌嗪衍生物及其盐、制备方法和用途
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CA3015285A1 (en) * 2016-03-24 2017-09-28 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
EP3500310A1 (en) 2016-08-20 2019-06-26 FTF Pharma Private Limited Pharmaceutical composition comprising an androgen receptor inhibitor
WO2019025153A1 (de) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Verwendung von substituierten n-sulfonyl-n'-aryldiaminoalkanen und n-sulfonyl-n'-heteroaryldiaminoalkanen oder deren salzen zur steigerung der stresstoleranz in pflanzen
CN111479560A (zh) 2017-10-16 2020-07-31 阿拉贡药品公司 用于治疗非转移性去势难治性前列腺癌的抗雄激素
LT3786160T (lt) 2017-10-27 2022-09-26 Boehringer Ingelheim International Gmbh Piridino dariniai ir jų terapinis panaudojimas kaip trpc6 inhibitorių
CN114761003B (zh) 2019-09-23 2023-12-29 冰洲石生物科技公司 具有雄激素受体降解活性的新型脲类及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL248308A (pt) * 1958-09-30
DE1239940B (de) * 1962-07-24 1967-05-03 Kalle Ag Lichtempfindliches Aufzeichnungsmaterial fuer Reproduktionszwecke
DE3063878D1 (en) * 1979-07-13 1983-07-28 Thomae Gmbh Dr K Derivatives of carboxylic acids, their preparation and medicaments containing them
GB8619472D0 (en) * 1986-08-09 1986-09-17 Pfizer Ltd Anti-arrhythmia agents
US5411981A (en) 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
WO1993010091A2 (en) * 1991-11-14 1993-05-27 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
DE4234295A1 (de) 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
GB9326373D0 (en) 1993-12-23 1994-02-23 Zeneca Ltd Chemical compounds
US5464788A (en) 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2722788B1 (fr) 1994-07-20 1996-10-04 Pf Medicament Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
CZ288002B6 (cs) 1995-01-11 2001-03-14 Samjin Pharmaceutical Co., Ltd. Piperazinové deriváty a farmaceutický prostředek s protinádorovou aktivitou je obsahující
AU6318896A (en) 1995-07-06 1997-02-05 Japan Tobacco Inc. Benzamidoxime derivatives and medicinal use thereof
TW357143B (en) 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
ZA968661B (en) 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
EP0850222B1 (en) 1996-06-29 2003-05-28 Samjin Pharmaceutical Co., Ltd. Piperazine derivatives and process for the preparation thereof
CA2264549C (en) * 1996-08-26 2004-09-14 Pfizer Inc. Spirocyclic dopamine receptor subtype ligands
FR2761066B1 (fr) 1997-03-24 2000-11-24 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AU735144B2 (en) * 1997-07-23 2001-07-05 Yamanouchi Pharmaceutical Co., Ltd. Novel hexahydro-1,4-diazepine derivatives or their salts
ID24372A (id) * 1997-10-27 2000-07-13 Agouron Pharma SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs

Also Published As

Publication number Publication date
CA2345146A1 (en) 2000-03-30
PL346795A1 (en) 2002-02-25
US20040010037A1 (en) 2004-01-15
EP1122242A1 (en) 2001-08-08
WO2000017163A1 (fr) 2000-03-30
CA2345146C (en) 2010-02-23
EP1122242B1 (en) 2008-01-16
KR100660309B1 (ko) 2006-12-22
ATE384048T1 (de) 2008-02-15
EP1122242A4 (en) 2004-12-01
DE69938005D1 (de) 2008-03-06
KR20010075268A (ko) 2001-08-09
US6673799B1 (en) 2004-01-06
DE69938005T2 (de) 2009-01-15
CN1319091A (zh) 2001-10-24
ES2300151T3 (es) 2008-06-01
AU754529B2 (en) 2002-11-21
AU5654499A (en) 2000-04-10
JP3390744B2 (ja) 2003-03-31
CN1129581C (zh) 2003-12-03

Similar Documents

Publication Publication Date Title
BR9914018A (pt) Derivado de cianofenila
NL350077I1 (nl) Cyprosulfamide
TR200000059T2 (tr) Piridin türevleri
BG105557A (en) Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
DE69910831D1 (de) Epothilonderivate und ihre verwendung als antitumormittel
YU21401A (sh) Tetrahidropiridoetri
DE69821985D1 (de) Ortho-anthranilamide derivate als antikoagulantien
DK0981341T3 (da) Anvendelse af betulinsyrederivater til behandling og forebyggelse af melanom
DE69929463D1 (de) Polyhydroxylierte heterocyclische derivate als antikoagulanten
BG104597A (en) Inhibition of raf kinase using substituted heterocyclic ureas
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
ATE290382T1 (de) Heterozyklische kalium-kanal inhibitoren
BG102003A (en) PYRIDO/2,3-d/PYRIMIDINES FOR THE INHIBITION OF CELLULAR PROLIFERATION CAUSED BY PROTEINTHYROSIKINASE
DK0946507T3 (da) Substituerede pyrrolylforbindelser til behandling af inflammation
WO1994004541A3 (en) Protein kinase inhibitors and related compounds combined with taxol
MX9700557A (es) Dihidrobenzofuranos.
TR199802767T2 (xx) Trombin �nleyiciler olarak yeni amidino t�revleri.
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
NO924121L (no) Substituerte pyrimidiner
CY1107149T1 (el) Νεα παραγωγα αμιδινοβενζυλαμινης και χρηση τους ως αναστολεων θρομβινης
DE69821530D1 (de) Dihydrobenzifurane
ATE287403T1 (de) 6-phenylbenzonaphthyidine
DE60036558D1 (de) Phthalazinon-derivate als pde 4 hemmer
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
BG106599A (en) Wood treatment

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1947 DE 29 - 04 - 2008.